XML 57 R45.htm IDEA: XBRL DOCUMENT v3.25.3
Investments (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Apr. 24, 2025
Jul. 31, 2023
Sep. 30, 2025
Sep. 30, 2024
Jun. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
May 19, 2023
Apr. 12, 2022
Equity Securities [Line Items]                    
Number of shares sold in transaction (in shares)         1,034,295          
Gain (loss) on investments, net     $ 678 $ 0   $ 5,018 $ (7,654)      
Shares of common stock sold (in shares)           143,161        
Provision for credit losses     17,566 0   $ 17,566 0      
Other comprehensive loss reclassifications, before Tax           3,500 0      
Gross unrealized gains     0     0        
Gross unrealized gains               $ 2,800    
Income (loss) from equity method investment, net of tax     38 $ (77)   11,783 $ 8,095      
Equity method investments     119,600     119,600   115,000    
Corporate Debt Security                    
Equity Securities [Line Items]                    
Investment in corporate debt security                   $ 15,000
Debt securities, available-for-sale, coupon rate                 6.00% 4.00%
Accrued interest receivable     0     0   2,100    
Debt securities, available-for-sale, accrued interest, allowance for credit loss     2,600     2,600   0    
Debt securities available for sale, amortized cost     0     0   $ 17,800    
Maximum exposure     $ 15,000     $ 15,000        
Corporate Debt Security | Minimum                    
Equity Securities [Line Items]                    
Debt securities, available-for-sale, term     1 year     1 year   1 year    
Corporate Debt Security | Maximum                    
Equity Securities [Line Items]                    
Debt securities, available-for-sale, term               5 years    
Disposal Group, Disposed of by Sale, Not Discontinued Operations | OpenEvidence                    
Equity Securities [Line Items]                    
Minority interest sold $ 29,700                  
Proceeds from divestiture $ 25,200                  
Shares of common stock sold (in shares) 143,161                  
OpenEvidence                    
Equity Securities [Line Items]                    
Equity securities without readily determinable fair value               $ 25,300    
OCV Fund                    
Equity Securities [Line Items]                    
Equity method investment distribution     $ 1,500     $ 10,800        
OpenEvidence                    
Equity Securities [Line Items]                    
Payments to acquire equity securities without readily determinable fair value   $ 25,000